These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 20506493

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
    Cui BB, Tian YR, Ma XY, Yin G, Xie Q.
    Front Immunol; 2021; 12():777502. PubMed ID: 34925350
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
    Nóvoa Medina FJ, Gutiérrez Martínez J, González González Y, Romero Díaz B, Machín García S, Rosas Romero A.
    Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.
    Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG.
    Ann Rheum Dis; 2006 Dec; 65(12):1635-8. PubMed ID: 16679430
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
    Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z, Zhang W, Lv H, Yuan Y.
    Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
    Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C, Qi Z, Koontz D, Levesque MC.
    Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J.
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [Abstract] [Full Text] [Related]

  • 14. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
    Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O.
    Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-SRP myopathy: different entity from myositis].
    Suzuki S.
    Rinsho Shinkeigaku; 2012 Jul; 52(11):1148-50. PubMed ID: 23196545
    [Abstract] [Full Text] [Related]

  • 18. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R, Moghadam-Kia S, Lacomis D, Malik A, Qi Z, Koontz D, Burlingame RW, Oddis CV.
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [Abstract] [Full Text] [Related]

  • 19. Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.
    Whelan BR, Isenberg DA.
    Rheumatology (Oxford); 2009 May; 48(5):594-5. PubMed ID: 19254917
    [No Abstract] [Full Text] [Related]

  • 20. Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.
    Fernandes das Neves M, Caetano J, Oliveira S, Delgado Alves J.
    BMJ Case Rep; 2015 Aug 03; 2015():. PubMed ID: 26240092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.